229.53
0.74%
1.69
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LH Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$227.84
Aprire:
$227.15
Volume 24 ore:
87,742
Relative Volume:
0.16
Capitalizzazione di mercato:
$19.02B
Reddito:
$12.71B
Utile/perdita netta:
$435.50M
Rapporto P/E:
30.69
EPS:
7.48
Flusso di cassa netto:
$843.20M
1 W Prestazione:
-0.62%
1M Prestazione:
-4.24%
6M Prestazione:
+10.34%
1 anno Prestazione:
+2.45%
Labcorp Holdings Inc Stock (LH) Company Profile
Nome
Labcorp Holdings Inc
Settore
Industria
Telefono
(336) 229-1127
Indirizzo
358 S MAIN ST, BURLINGTON, NC
Confronta LH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
229.45 | 19.02B | 12.71B | 435.50M | 843.20M | 5.15 |
TMO
Thermo Fisher Scientific Inc
|
527.55 | 200.97B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
230.40 | 165.39B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
135.67 | 38.49B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
199.50 | 36.08B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
413.58 | 33.79B | 3.84B | 866.24M | 792.60M | 10.37 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-10 | Ripresa | Jefferies | Buy |
2024-10-30 | Aggiornamento | HSBC Securities | Hold → Buy |
2024-10-01 | Iniziato | Piper Sandler | Neutral |
2024-03-25 | Aggiornamento | Argus | Hold → Buy |
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2024-02-09 | Iniziato | Evercore ISI | In-line |
2024-01-03 | Iniziato | Barclays | Equal Weight |
2023-09-06 | Iniziato | HSBC Securities | Hold |
2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
2022-09-19 | Downgrade | Argus | Buy → Hold |
2022-08-22 | Ripresa | Morgan Stanley | Overweight |
2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
2021-01-11 | Aggiornamento | Argus | Hold → Buy |
2021-01-11 | Downgrade | Wolfe Research | Peer Perform → Underperform |
2021-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
2020-07-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2020-06-02 | Ripresa | Deutsche Bank | Buy |
2020-05-15 | Aggiornamento | Mizuho | Neutral → Buy |
2020-04-29 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
2020-01-08 | Iniziato | Wells Fargo | Overweight |
2019-07-16 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
2019-06-21 | Aggiornamento | Deutsche Bank | Hold → Buy |
2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
2019-01-17 | Iniziato | UBS | Buy |
2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
2018-12-03 | Downgrade | Craig Hallum | Buy → Hold |
2018-10-30 | Downgrade | Argus | Buy → Hold |
2018-10-25 | Downgrade | Canaccord Genuity | Buy → Hold |
2018-10-19 | Ripresa | BofA/Merrill | Buy |
2018-06-07 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
2018-05-01 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2018-03-23 | Iniziato | Argus | Buy |
Mostra tutto
Labcorp Holdings Inc Borsa (LH) Ultime notizie
Labcorp Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Labcorp Settles Competition Suit Against Ex-Sales Exec - Law360
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal - MSN
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain? - Yahoo Finance
Labcorp Declares Quarterly Dividend - Kilgore News Herald
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Labcorp bird flu test takes flight - BioWorld Online
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians - Marketscreener.com
Labcorp releases H5 bird flu test as outbreak spreads By Investing.com - Investing.com Canada
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians – Company Announcement - Financial Times
Labcorp's SWOT analysis: new CFO, strong Q2 drive stock outlook By Investing.com - Investing.com Australia
Labcorp Agrees to Acquire Certain Legacy Health Outreach Laboratory Business Assets - Marketscreener.com
Labcorp's SWOT analysis: new CFO, strong Q2 drive stock outlook - Investing.com
Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033 - GlobeNewswire Inc.
Labcorp Forges Strategic Partnership with Tufts Medicine, Will A - GuruFocus.com
Labcorp closes takeover of Ballad Health outreach laboratory services - Yahoo Finance
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp Accuses Ex-Sales Exec Of Stealing Customers - Law360
Labcorp to Speak at the Baird 2024 Global Healthcare Conference - The Eastern Progress Online
In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 - GlobeNewswire Inc.
Those who invested in Labcorp Holdings (NYSE:LH) five years ago are up 70% - Simply Wall St
Jefferies initiates Laboratory Corp with Buy, sets $275 target By Investing.com - Investing.com Canada
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - The Eastern Progress Online
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - The Eastern Progress Online
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Mercy BioAnalytics, Inc. announced that it expects to receive $59.999993 million in funding - Marketscreener.com
Insider Sell: Dwight Gilliland Sells 1,000 Shares of Labcorp Hol - GuruFocus.com
Labcorp director sells $241,000 in common stock - Investing.com
Labcorp executive sells $2.8 million in stock - Investing.com
Labcorp director sells $241,000 in common stock By Investing.com - Investing.com UK
Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand - Seeking Alpha
Labcorp to Acquire Select Assets From AtlantiCare - Marketscreener.com
Labcorp's EVP Amy Summy sells shares worth $877,141 By Investing.com - Investing.com Canada
Labcorp's EVP Amy Summy sells shares worth $877,141 - Investing.com India
Is Wall Street Bullish or Bearish on Labcorp Holdings Stock? - MSN
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients - Yahoo Finance
Is Wall Street Bullish Or Bearish On Labcorp Holdings Stock? - Barchart
Labcorp's EVP Sandra van der Vaart sells $239,418 in stock - Investing.com India
Insider Sell: van der Vaart Sandra D Sells 1,000 Shares of Labco - GuruFocus.com
Labcorp's EVP Sandra van der Vaart sells $239,418 in stock By Investing.com - Investing.com Canada
At US$240, Is It Time To Put Labcorp Holdings Inc. (NYSE:LH) On Your Watch List? - Yahoo Finance
Ex-Dividend Reminder: Avista, Johnson & Johnson and Labcorp Holdings - Nasdaq
Labcorp Holdings Inc Azioni (LH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):